A2M

What is A2M Therapy?

Alpha-2-Macroglobulin (A2M) therapy represents a significant advancement in the treatment of joint degeneration and arthritis. A2M is a naturally occurring protein in the blood that acts as a broad-spectrum protease inhibitor, targeting and neutralizing enzymes that degrade cartilage and contribute to osteoarthritis. The therapy involves concentrating this protein from a patient’s blood and injecting it directly into the affected joint or tissue, where it can prevent further cartilage breakdown and inflammation.

The benefits of A2M therapy are multifaceted. Firstly, it provides a potent defense against the enzymes responsible for cartilage degradation, which is crucial in slowing the progression of osteoarthritis. By inhibiting these harmful enzymes, A2M helps to preserve existing cartilage and joint function. Additionally, A2M has anti-inflammatory properties, reducing pain and swelling in the joint, which can significantly improve the quality of life for patients suffering from chronic joint pain.

What is the A2M Therapy Procedure?

At Lone Star Biogenetics the process of administering A2M therapy is straightforward yet highly specialized. It begins with blood drawn from the patient. The blood collected from the patient is then spun down in a specialized centrifuge and filtered repeatedly to concentrate the A2M protein. This concentrated solution is injected into the affected area using state of the art imaging machine to ensure precise delivery. Patients typically experience an initial period of soreness due to the injection, followed by significant improvements in pain and joint function within a few days as the A2M begins to take effect.

The Next Step

A2M therapy will seek out and destroy the cause of degeneration. PRP therapy involves concentrating platelets from a patient’s blood to harness their growth factors, which stimulate tissue repair and regeneration. It is commonly used for chronic tendon injuries and mild to moderate osteoarthritis.

At Lone Star Biogenetics we are ready to bring these new treatments to you .